Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
raleigh-durham blog main
8
×
san francisco blog main
biotech
life sciences
national top stories
national
new york blog main
san francisco top stories
boston blog main
detroit blog main
medical device
raleigh-durham top stories
san diego blog main
seattle blog main
texas blog main
texas top stories
wisconsin blog main
boston top stories
boulder/denver blog main
cancer
cancer diagnostics
clinical trials
detroit top stories
indiana blog main
medical devices
merck
seattle top stories
startups
abbvie
arvinas
boulder/denver top stories
deals
detroit
fda
indiana top stories
innovation
johnson & johnson
multiple myeloma
new york top stories
What
company
8
×
life
science
business
developing
firms
investors
ipo
leaders
make
medical
pfizer
plans
tests
week
acelity
acquisitions
adding
aims
albert
ann
antonio
arbor
based
biggest
bio
biotechs
blood
bourla
broader
cancer
cash
ceo
chose
clearance
close
closed
comes
control
crispr
Language
unset
unknown
Current search:
xconomy.com
×
company
×
" raleigh-durham blog main "
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
San Antonio Life Science Business Acelity Cuts 260 Jobs in Texas, NC
@xconomy.com
5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round